HBC Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3K | Hold |
150
| – | – | ﹤0.01% | 153 |
|
|
2024
Q3 | $4K | Sell |
150
-304
| -67% | -$8.11K | ﹤0.01% | 147 |
|
|
2024
Q2 | $13K | Buy |
454
+4
| +0.9% | +$115 | 0.01% | 107 |
|
|
2024
Q1 | $12K | Buy |
450
+5
| +1% | +$133 | 0.01% | 105 |
|
|
2023
Q4 | $12K | Buy |
445
+4
| +0.9% | +$108 | 0.01% | 105 |
|
|
2023
Q3 | $14K | Buy |
441
+3
| +0.7% | +$95 | 0.01% | 104 |
|
|
2023
Q2 | $15K | Buy |
438
+3
| +0.7% | +$103 | 0.01% | 97 |
|
|
2023
Q1 | $17K | Buy |
435
+103
| +31% | +$4.03K | 0.01% | 119 |
|
|
2022
Q4 | $16K | Buy |
332
+2
| +0.6% | +$96 | 0.01% | 97 |
|
|
2022
Q3 | $14K | Buy |
330
+3
| +0.9% | +$127 | 0.01% | 100 |
|
|
2022
Q2 | $17K | Buy |
327
+2
| +0.6% | +$104 | 0.01% | 103 |
|
|
2022
Q1 | $15K | Buy |
325
+2
| +0.6% | +$92 | 0.01% | 105 |
|
|
2021
Q4 | $19K | Buy |
323
+2
| +0.6% | +$118 | 0.01% | 104 |
|
|
2021
Q3 | $13K | Buy |
321
+52
| +19% | +$2.11K | 0.01% | 107 |
|
|
2021
Q2 | $10K | Buy |
269
+3
| +1% | +$112 | 0.01% | 128 |
|
|
2021
Q1 | $10K | Buy |
266
+2
| +0.8% | +$75 | 0.01% | 127 |
|
|
2020
Q4 | $10K | Sell |
264
-11
| -4% | -$417 | 0.01% | 133 |
|
|
2020
Q3 | $10K | Buy |
275
+3
| +1% | +$109 | 0.01% | 130 |
|
|
2020
Q2 | $9K | Sell |
272
-1,431
| -84% | -$47.3K | 0.01% | 115 |
|
|
2020
Q1 | $51K | Buy |
1,703
+3
| +0.2% | +$90 | 0.06% | 51 |
|
|
2019
Q4 | $63K | Buy |
+1,700
| New | +$63K | 0.05% | 60 |
|